Report updated Apr 20, 2026
Morphin
For users interested in the Graphics & Design category who prefer a one-time purchase model over subscription-based design software.
Morphin is an established graphics & design app that is a paid app. With a 3.8/5 rating from 9 reviews, it shows polarized user reception.
What is Morphin?
Current Momentum
v3.8
-added projects page -removed some bloatware, thereby improving performances and fixing some bugs -improved bezier interpolation, feels more smooth and natural -added rig wizard to speed up rig creation -added mirror bone weight in mirror menu -added smear option for weight paint -improved constraint UI (introduced picker) -localization (French, Chinese, Japanese, etc.)
Active Nemesis
Face Swap Live
By AI Tools Apps SRL
Other Rivals
7-Day Rank Pulse 🇺🇸
Graphics & DesignRating Pulse 🇺🇸
What makes this app unique?
Loading...
What Are The Key Features?
A single $24.99 transaction providing full access without recurring fees.
Messaging focused on direct ownership and high-end design utility.
How much does it cost?
- One-time purchase price of $24.99
The app uses a high-barrier upfront payment to target a niche audience that dislikes subscriptions. This is a bold strategy given that competitors like Faceover Pro offer similar utility for less.
Who Built It?
Providing premium design tools for users who prefer direct ownership over subscription models.
Portfolio
1
Apps
Explore the full Ademola Adenekan report
Portfolio breakdown, audience, momentum, and every app published by Ademola Adenekan.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Morphin?
How's The Graphics & Design Market?
How does it evolve in the Graphics & Design market?
Rank progression
9 active rankings tracked — 30-day window
The rivals identified
The outtake for Morphin
Strengths to defend, gaps to attack
Core Strengths
- Transparent one-time pricing model
- Premium brand positioning
- Direct ownership value proposition
Critical Frictions
- High entry price ($24.99) without a free trial
- Lack of developer website or social media presence
- Zero visible ratings or reviews in current data
Growth Levers
- Capitalize on subscription fatigue in the creative software market
- Add multi-face swapping to compete with Faceover Pro
- Introduce high-definition video morphing
Market Threats
- Downward ranking trend (#46, ↓5) in the US Paid category
- Cheaper legacy competitors offering similar features
- Rapid AI innovation from venture-backed competitors like Reface
What are the next best moves?
Conduct a price sensitivity analysis against Faceover Pro.
Faceover Pro is identified as a contender with a lower one-time purchase price, making Morphin's $24.99 tag a significant churn/acquisition risk.
Develop and market a 'Multi-Face' feature.
This is a specific feature gap identified in the competitor analysis for Faceover Pro that Morphin currently lacks.
Establish a basic web and social presence.
The lack of developer info and social links for a $24.99 app creates a trust deficit that likely contributes to the ranking decline (↓5).
Feature Gaps vs Competitors
- Multi-face swapping (available in Faceover Pro)
- Real-time video face swapping (available in FaceSwap Live)
- Community-based content remixing (available in Remix: AI Photo Editor)
- High-definition video morphing (available in FaceMagic)
Key Takeaways
If I were the PM for Morphin, I would immediately address the lack of social proof and the high price barrier. While the 'no-subscription' model is a strong differentiator, the current $24.99 price point is difficult to justify without a visible feature advantage over cheaper contenders like Faceover Pro or the high-tech AI capabilities of Reface.
Where Is It Heading?
Declining
Ranked #46 Paid (↓5) in US Category 6027 — indicates loss of market momentum.
Premium pricing maintained at $24.99 — high barrier to entry in a competitive market.